3C-P
| Clinical data | |
|---|---|
| Other names | 4-Propoxy-3,5-dimethoxyamphetamine; 3,5-Dimethoxy-4-propoxyamphetamine; α-Methylproscaline; 3C-Proscaline |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
3C-P, also known as 4-propoxy-3,5-dimethoxyamphetamine or as α-methylproscaline (3C-proscaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA). It is the amphetamine (3C) analogue of proscaline.